NCT07229807
Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 13 words Show 4 more changesShow less
- Trial completed
- Primary completion date changed from estimate of Dec 17, 2025 to Jan 17, 2026
- Enrollment target: estimated 119 to confirmed 120
- Study completion date changed from estimate of Dec 31, 2025 to Jan 21, 2026
Minor Trial status: Not Yet Recruiting to Active, Not Recruitingv3 Show 5 more changesShow less
- Enrollment target: 114 to 119
- Primary completion date: Jun 17, 2026 to Dec 17, 2025
- Study completion date: Sep 17, 2026 to Dec 31, 2025
- Start date changed from estimate of Nov 30, 2025 to Nov 22, 2025
- Site contact updated
- Minor Secondary endpoints: details revised at 1 of 2 entriesv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Time to Alleviation of Symptoms
Timeframe: DAY1~DAY15
Secondary (2)
Plasma concentrations of ZSP1273
Number of participants with treatment-related adverse events as assessed by CTCAE v5.0
Arms and interventions
ZSP1273Experimental
OseltamivirActive comparator
Drugs: ZSP1273, Oseltamivir
Sites
1 site in 1 country
- Beijing Children HospitalBeijing, China